FcγR2B B2 .4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients-Reference-Cited by-同舟云学术

FcγR2B B2 .4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients

Published:2020-05-04 Issue:7 Volume:60 Page:1573-1578
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Costa Neto Abel¹,Santos Flávia²,Ribeiro Ingrid¹³,Oliveira Valeria¹³,Dezan Marcia¹³,Kashima Simone²,Covas Dimas²,Pereira Alexandre⁴,Fonseca Guilherme¹,Moreira Frederico¹,Krieger José⁴,Gualandro Sandra¹,Rocha Vanderson¹⁵,Mendrone Alfredo¹,Dinardo Carla L.¹³

Affiliation:

1. Serviço de HematologiaHemoterapia e Terapia Celular do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo/Instituto do Câncer do Estado de São Paulo São Paulo Brazil

2. Regional Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão PretoUniversity of São Paulo Ribeirão Preto Brazil

3. Institute of Tropical MedicineUniversity of São Paulo São Paulo Brazil

4. Laboratory of Genetics and Molecular CardiologyHeart Institute (InCor), University of São Paulo São Paulo Brazil

5. Department of HematologyChurchill Hospital, NHS BT, Oxford University Oxford UK

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15832

Reference30 articles.

1. Study of possible clinical and laboratory predictors of alloimmunization against red blood cell antigens in cancer patients